Cervical Cancer Screening in the 21st Century: Is it Time to Retire the PAP Smear?
- 1 June 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Obstetrics and Gynecology
- Vol. 50 (2), 313-323
- https://doi.org/10.1097/grf.0b013e31804a8285
Abstract
Although cytology-based cervical cancer prevention programs have reduced the incidence of cervical cancer in many industrialized countries, the limited sensitivity of cervical cytology makes these programs difficult and expensive to maintain. There- fore, over the next several years it is likely that we will begin to switch from cervical cytology-based screening programs to programs based on testing for high-risk types of human papillomavirus (HPV). Multiple large, well-controlled screening trials have clearly demonstrated that HPV testing is consider- ably more sensitive than cytology (either conven- tional or liquid-based) and only slightly less specific when used in women 30 years of age and older. Initially, we will use a combination of cervical cytology and HPV testing to screen, but as more data from large screening studies become available, it is becoming clear that cytology provides little benefit over using HPV testing alone to screen. Therefore, in the future it is likely that we will use HPV testing alone to screen, and reserve cervical cytology as a way to determine which HPV-positive women require additional follow-up or colposcopy.Keywords
This publication has 17 references indexed in Scilit:
- Chapter 7: Achievements and limitations of cervical cytology screeningVaccine, 2006
- Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trialThe Lancet Oncology, 2006
- Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled TrialJNCI Journal of the National Cancer Institute, 2006
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic reviewThe Lancet, 2006
- Direct comparison of liquid‐based and conventional cytology in a South African screening trialInternational Journal of Cancer, 2005
- Management of women who test positive for high-risk types of human papillomavirus: the HART studyThe Lancet, 2003
- Accuracy of the Papanicolaou Test in Screening for and Follow-up of Cervical Cytologic AbnormalitiesAnnals of Internal Medicine, 2000
- Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statisticsBMJ, 1999
- Missed Opportunities for Cervical Cancer Screening of HMO Members Developing Invasive Cervical Cancer (ICC)Gynecologic Oncology, 1998